Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Portal Hypertension
How do you utilize urine sodium and potassium levels and ratios in diuretic optimization in patients with ascites?
Related Questions
What is your strategy to manage peri-procedural bleeding risk in patients with cirrhosis?
How does the presence of porto-mesenteric vein thrombosis impact a patient's transplant candidacy?
What patient clinical factors do you find most impact a patient's "beta-blocker window" and their ability to maintain and tolerate beta-blocker therapy?
How do you determine the timing and frequency of therapeutic thoracentesis in patients with symptomatic hepatic hydrothorax?
How do you decide between empiric carvedilol versus obtaining HVPG to confirm CSPH when noninvasive markers suggest CSPH but there is limited hemodynamic/renal reserve (borderline MAP and/or CKD)?
Who would be the right candidate in which TIPS placement would reduce portal hypertension to allow for a previously unattainable procedure?
What clinical scenario would you favor NOT using terlipressin for the management of HRS if there were no notable contraindications for its initiation?
In patients who meet Baveno VII NIT criteria for CSPH and are candidates for NSBB to prevent decompensation, when (if ever) do you still perform screening endoscopy before starting NSBB, and what specific findings would change your management?
What is your endoscopic approach to the management of refractory GAVE in persistently anemic patients?
How do you balance the need for diuretics from a volume perspective (Ex: ascites, edema) in decompensated cirrhotic patients and progressive renal dysfunction?
